Form 4: Ironwood Pharmaceuticals CFO Sells Shares to Cover Tax Obligations

Gregory S. Martini, CFO of Ironwood Pharmaceuticals, sold 12,052 shares of Class A Common Stock on February 10, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On February 10, 2025, Gregory S. Martini, the Chief Financial Officer of Ironwood Pharmaceuticals, sold 12,052 shares of Class A Common Stock.
• The shares were sold at a weighted average price of $1.76.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Martini directly owns 183,810 shares of Ironwood Pharmaceuticals.
• The sale was not a discretionary trade but an automatic sell-to-cover transaction to satisfy tax obligations.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell-to-cover for tax obligations) and doesn't indicate any significant positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This transaction is a common practice to cover tax obligations related to equity compensation.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but the stated reason (tax obligations) mitigates potential concerns.

Key Dates

Keywords

Ironwood Pharmaceuticals, IRWD, Gregory S. Martini, CFO, stock sale, Form 4, tax withholding, restricted stock units, sell-to-cover